Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912692341> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2912692341 abstract "Medin is a common amyloid protein that accumulates in cerebral vessels with aging and cause endothelial dysfunction in human cerebral arterioles. Studying its role in cerebrovascular disease could provide insights on cerebrovascular aging. We aim to test whether medin induces pro-inflammatory priming of endothelial cells (ECs) and probe mechanistic bases, and determine whether monosialoganglioside-containing nanoliposomes (NLGM1), previously shown to protect against AL amyloid vascular dysfunction, would abrogate this response. Methods: Human umbilical vein ECs were treated (20 hours) with physiologic dose of medin (5 μM) or vehicle, and proinflammatory markers IL-1β, caspase-1, IL-8, IL-6, ICAM-1, phospho-NFκB and pro-thrombotic marker plasminogen activator inhibitor-1 (PAI-1) gene and/or protein expressions were measured. In some replicates, medin was co-treated with either specific NFκB small molecule inhibitor RO106-9920 100 μM or NLGM1 (70:20:5% phosphatidylcholine, cholesterol, monosialoganglioside, 1:10 medin:NLGM1 mass ratio). Results: Medin increased gene expression of IL-1β (104.0±30.2x vs. control, p=0.002), IL-8 (5560±1864x, p<0.001), IL-6 (80.4±48x, p<0.001), ICAM-1 (72.0±8.5x, p<0.001) and PAI-1 (5.4±1x, p<0.001) (n=13-44). There were corresponding increases in protein expression as well as increased phospho-NFκB and caspase-1 (Figure). RO106-9920 co-treatment reduced gene expressions of IL-8, IL-6, ICAM-1 and PAI-1 but not IL-1β (versus medin treatment) whereas NLGM1 normalized gene expressions of all cytokines including IL-1β. Conclusions: Medin induced profound proinflammatory and prothrombotic responses in endothelial cells. Both NFκB and inflammasome-mediated mechanisms mediate medin’s vascular priming effects. Medin-induced pathology is a potential new mechanism of aging-related cerebrovascular inflammation. NLGM1 protects against medin’s effects and may represent a new therapeutic approach." @default.
- W2912692341 created "2019-02-21" @default.
- W2912692341 creator A5015045338 @default.
- W2912692341 creator A5033012778 @default.
- W2912692341 creator A5034000086 @default.
- W2912692341 creator A5046394948 @default.
- W2912692341 creator A5054321132 @default.
- W2912692341 creator A5076508749 @default.
- W2912692341 creator A5080433759 @default.
- W2912692341 creator A5081140590 @default.
- W2912692341 date "2019-02-01" @default.
- W2912692341 modified "2023-09-26" @default.
- W2912692341 title "Abstract TP557: Endothelial Cell Proinflammatory Priming by Amyloidogenic Medin via NFκB and Inflammasome Pathways and Reversal by Monosialoganglioside Nanoliposomes" @default.
- W2912692341 doi "https://doi.org/10.1161/str.50.suppl_1.tp557" @default.
- W2912692341 hasPublicationYear "2019" @default.
- W2912692341 type Work @default.
- W2912692341 sameAs 2912692341 @default.
- W2912692341 citedByCount "0" @default.
- W2912692341 crossrefType "journal-article" @default.
- W2912692341 hasAuthorship W2912692341A5015045338 @default.
- W2912692341 hasAuthorship W2912692341A5033012778 @default.
- W2912692341 hasAuthorship W2912692341A5034000086 @default.
- W2912692341 hasAuthorship W2912692341A5046394948 @default.
- W2912692341 hasAuthorship W2912692341A5054321132 @default.
- W2912692341 hasAuthorship W2912692341A5076508749 @default.
- W2912692341 hasAuthorship W2912692341A5080433759 @default.
- W2912692341 hasAuthorship W2912692341A5081140590 @default.
- W2912692341 hasConcept C126322002 @default.
- W2912692341 hasConcept C134018914 @default.
- W2912692341 hasConcept C164027704 @default.
- W2912692341 hasConcept C203014093 @default.
- W2912692341 hasConcept C2776914184 @default.
- W2912692341 hasConcept C2777209026 @default.
- W2912692341 hasConcept C71924100 @default.
- W2912692341 hasConceptScore W2912692341C126322002 @default.
- W2912692341 hasConceptScore W2912692341C134018914 @default.
- W2912692341 hasConceptScore W2912692341C164027704 @default.
- W2912692341 hasConceptScore W2912692341C203014093 @default.
- W2912692341 hasConceptScore W2912692341C2776914184 @default.
- W2912692341 hasConceptScore W2912692341C2777209026 @default.
- W2912692341 hasConceptScore W2912692341C71924100 @default.
- W2912692341 hasIssue "Suppl_1" @default.
- W2912692341 hasLocation W29126923411 @default.
- W2912692341 hasOpenAccess W2912692341 @default.
- W2912692341 hasPrimaryLocation W29126923411 @default.
- W2912692341 hasRelatedWork W1966504330 @default.
- W2912692341 hasRelatedWork W1979139803 @default.
- W2912692341 hasRelatedWork W2037631372 @default.
- W2912692341 hasRelatedWork W2134360092 @default.
- W2912692341 hasRelatedWork W2161707322 @default.
- W2912692341 hasRelatedWork W2175375539 @default.
- W2912692341 hasRelatedWork W2748952813 @default.
- W2912692341 hasRelatedWork W3003308701 @default.
- W2912692341 hasRelatedWork W3038304001 @default.
- W2912692341 hasRelatedWork W628893562 @default.
- W2912692341 hasVolume "50" @default.
- W2912692341 isParatext "false" @default.
- W2912692341 isRetracted "false" @default.
- W2912692341 magId "2912692341" @default.
- W2912692341 workType "article" @default.